All Manufacturers, Suppliers, Distributors and Exporters of Loxoprofen with Listed Dossiers of Finished Dosage Form listed on PharmaCompass.com

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 226721-96-6, Loxonin, Oxeno, Lobu, Loxoprofen sodium, Loxoprofen sodium hydrate
Molecular Formula
C15H21NaO5
Molecular Weight
304.31  g/mol
InChI Key
BAZQYVYVKYOAGO-UHFFFAOYSA-M
FDA UNII
Z2DR42L11Y

Loxoprofen Sodium
1 2D Structure

Loxoprofen Sodium

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;2-[4-[(2-oxocyclopentyl)methyl]phenyl]propanoate;dihydrate
2.1.2 InChI
InChI=1S/C15H18O3.Na.2H2O/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16;;;/h5-8,10,13H,2-4,9H2,1H3,(H,17,18);;2*1H2/q;+1;;/p-1
2.1.3 InChI Key
BAZQYVYVKYOAGO-UHFFFAOYSA-M
2.1.4 Canonical SMILES
CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)[O-].O.O.[Na+]
2.2 Other Identifiers
2.2.1 UNII
Z2DR42L11Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 156-s

2. 2-(4-((2-oxocyclopentyl)methyl)phenyl)propionic Acid

3. 2-ocppp

4. Cs 600

5. Cs-600

6. Loxoprofen

7. Loxoprofen Alcohol

8. Loxoprofen Sodium, (r*,s*)-isomer

9. Sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate Dihydrate

10. Sodium Loxoprofen

2.3.2 Depositor-Supplied Synonyms

1. 226721-96-6

2. Loxonin

3. Oxeno

4. Lobu

5. Loxoprofen Sodium

6. Loxoprofen Sodium Hydrate

7. Loxoprofen Sodium Salt Dihydrate

8. 80382-23-6

9. Loxoprofen Sodium [mart.]

10. Loxoprofen Sodium Hydrate [jp]

11. Loxoprofen (monosodium)

12. Lobu; Loxonin;cs 600

13. Sodium;2-[4-[(2-oxocyclopentyl)methyl]phenyl]propanoate;dihydrate

14. Z2dr42l11y

15. Monosodium 2-(4-((2-oxocyclopentyl)methyl)phenyl)propanoate Dihydrate

16. Sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate Dihydrate

17. Alpha-methyl-4-((2-oxocyclopentyl)methyl)benzeneacetate Sodium Salt Dihydrate

18. Unii-z2dr42l11y

19. Lorfenamin (tn)

20. Loxonin (tn)

21. Loxoprofensodiumdihydrate

22. Chebi:31786

23. Dtxsid601001203

24. Loxoprofen Sodium Hydrate (jp17)

25. Bja72196

26. Ac-555

27. Mfcd01745788

28. Akos015894920

29. Akos015963323

30. Benzeneacetic Acid, Alpha-methyl-4-((2-oxocyclopentyl)methyl)-, Sodium Salt, Hydrate (1:1:2)

31. (r)-2-chloro-3-methylbutyricacid

32. As-82727

33. Loxoprofen Sodium Dihydrate [who-dd]

34. D01709

35. Q27114685

36. Sodium 2-[4-(2-oxocyclopentylmethyl) Phenyl]-propionate Dihydrate

37. Sodium 2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoate--water (1/1/2)

38. Sodium 2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoate--water (1/2)

39. Benzeneacetic Acid, .alpha.-methyl-4-((2-oxocyclopentyl)methyl)-, Sodium Salt, Hydrate (1:1:2)

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 304.31 g/mol
Molecular Formula C15H21NaO5
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass304.12866805 g/mol
Monoisotopic Mass304.12866805 g/mol
Topological Polar Surface Area59.2 â„в
Heavy Atom Count21
Formal Charge0
Complexity321
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count2
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count4
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Inflammatory Agents, Non-Steroidal

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)


API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q2","strtotime":1623781800,"product":"LOXOPROFEN SODIUM HYDRATE","address":"PLOT NO.135, DR.NO.10-153\/1,","city":"VISAKHAPATNAM, ANDHRA PRADESH","supplier":"NULINK CO., LTD., JAPAN","supplierCountry":"JAPAN","foreign_port":"TOKYO","customer":"EISAI","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"25","unit":"GMS","unitRateFc":"0.1","totalValueFC":"2","currency":"USD","unitRateINR":"5.9","date":"16-Jun-2021","totalValueINR":"148","totalValueInUsd":"2","indian_port":"Vizag-RPCIPL SEZ","hs_no":"29420090","bill_no":"1000876","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"TOKYO","supplierAddress":"N\/A","customerAddress":"PLOT NO.135, DR.NO.10-153\/1,"}]
16-Jun-2021
16-Jun-2021
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Annual Reports

read-more
read-more

01

Brand Name : Loxonin

Loxoprofen

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2020 Revenue in Millions : 225

2019 Revenue in Millions : 265

Growth (%) : -15

blank

02

Brand Name : Loxonin

Loxoprofen

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2021 Revenue in Millions : 192

2020 Revenue in Millions : 224

Growth (%) : -8

blank

03

Brand Name : Loxonin

Loxoprofen

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2022 Revenue in Millions : 148

2021 Revenue in Millions : 192

Growth (%) : -23

blank

04

Brand Name : Loxonin

Loxoprofen Sodium

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen Sodium

Main Therapeutic Indication : Musculoskeletal

Currency : USD

2023 Revenue in Millions : 111

2022 Revenue in Millions : 148

Growth (%) : -16

blank

05

Brand Name : Loxonin

Loxoprofen

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen

Main Therapeutic Indication : Anti-inflammatory

Currency : USD

2017 Revenue in Millions : 376

2016 Revenue in Millions : 356

Growth (%) : 6

blank

06

Brand Name : Loxonin

Loxoprofen

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen

Main Therapeutic Indication : Anti-Inflammatory

Currency : USD

2018 Revenue in Millions : 286

2017 Revenue in Millions : 353

Growth (%) : -19%

blank

07

Brand Name : Loxonin

Loxoprofen

arrow
BioProcess International
Not Confirmed

Brand Name : Loxonin

Japan
arrow
BioProcess International
Not Confirmed

Loxoprofen

Main Therapeutic Indication : Infectious Diseases

Currency : USD

2019 Revenue in Millions : 269

2018 Revenue in Millions : 296

Growth (%) : -9

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty